Recombinant Human IL-10 (Preventec)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRecombinant Human IL-10 (Preventec)
Drug Alias NameN/A
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesHypersensitivityImmune System Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPrevenTec Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPrevenTec Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesHypersensitivityImmune System Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A